From Company Creation through Public Investing
The Frazier Life Sciences team invests in and builds companies developing and commercializing novel therapeutics.
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Frazier Lifesciences Acquisition Corporation Announces Pricing of Upsized $120 Million Initial Public Offering
